Because we were pioneers in highlighting the regulation of miR-146a for astrocyte neuroprotective effects in ALS models [43], we treated the most depleted mSOD1-ALS2 and sALS7 iAstrocytes with pre-miR-146a. This evidence concerns the gene ALS2 and amyotrophic lateral sclerosis.